HSA (Human Serum Albumin) long-acting fusion protein and rapid assembly, separation and purification method thereof

A technology for separation and purification of fusion proteins, applied in the field of long-acting fusion protein drugs, can solve the problems of decreased biological activity of proteins, multiple steps, and reduced immunogenicity of proteins

Inactive Publication Date: 2014-03-05
INST OF BIOENG ACAD OF MILITARY MEDICAL SCI OF THE CHINESE
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The content of natural products is less, while the chemically synthesized Exendin-4 has disadvantages such as high cost, high price, many steps, low yield, and harmful chemicals involved in the synthesis process
The retention time of protein drugs in the body greatly affects the dosage and therapeutic effect of drugs. In recent years, scholars at home and abroad mainly extend the half-life of protein drugs from chemical modification and gene fusion. The most widely used chemical modification The modifier is PEG, which can prolong the half-life by several tens of times or even hundreds of times, but the immunogenicity of most proteins will be reduced, and the biological activity of proteins will also decrease to varying degrees
[0005] Human serum albumin (Human serum albumin, HSA) is the main protein component in plasma, and it is also the carrier of many endogenous factors and exogenous drugs, and plays a very important role in maintaining osmotic pressure and plasma volume in the body; under normal conditions, the kidney low clearance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • HSA (Human Serum Albumin) long-acting fusion protein and rapid assembly, separation and purification method thereof
  • HSA (Human Serum Albumin) long-acting fusion protein and rapid assembly, separation and purification method thereof
  • HSA (Human Serum Albumin) long-acting fusion protein and rapid assembly, separation and purification method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0043] Such as Picture 1-1 and Figure 1-2 Shown is a schematic diagram of the rapid assembly, separation and purification method of the HAS long-acting fusion protein of the present invention and the construction of pPICZαA-E4-HSA. The present invention utilizes the BglBrick method to quickly assemble, separate and purify HSA long-acting fusion protein, amplify HSAcDNA from a plasmid containing HSA cDNA by PCR, and add XhoⅠBglⅡ and BamHINotⅠ enzyme cutting sites to the N-terminus and C-terminus of the HSA cDNA fragment respectively point; by artificially synthesizing the Exendin-4 fragment, and adding XhoⅠBglⅡ and BamHⅠNotⅠ restriction sites at the N-terminal and C-terminal of the fragment respectively; connecting the two fragments to the pPICZαA expression vector respectively, and combining XhoⅠBamHI and XhoⅠBglⅡ to the vector plasmid Cutting and linking of fragments can quickly assemble the HSA long-acting fusion protein expression vector; the HSA long-acting fusion protei...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an HSA (Human Serum Albumin) long-acting fusion protein and a rapid assembly, separation and purification method thereof. The fusion protein comprises two polypeptide regions, wherein the first region is formed by a repetitive sequence of Exendin-4, the second region is formed by a sequence of the HSA, the C-end of the first region is connected with the N-end of the second region via glycine and serine, or the N-end of the first region is connected with the C-end of the second region via glycine and serine. The Exendin-4 is repeated for once to 4 times, and the repetitive sequence of the Exendin-4 is directly connected via glycine and serine. By adopting a Bglbrick method by the invention, an arbitrary number of Exendin-4 can be arbitrarily added on the N-end or C-end of the HSA, then high-purity fusion protein is acquired through expression and purification.

Description

technical field [0001] The present invention relates to a long-acting fusion protein of HSA (Human serum albumin, Human serum albumin) and its rapid assembly, separation and purification method, specifically the rapid assembly, separation and purification of HSA long-acting fusion protein by using the Bglbrick method, which belongs to the long-acting The technical field of fusion protein medicine. technical background [0002] The Biobrick / Bglbrick method is a different-scale DNA in vitro assembly method based on the idea of ​​ligation or aggregation. The birth of this method has accelerated the artificial construction of synthetic biological functional component libraries, biosynthetic pathways and even yeast chromosomes, and promoted metabolic engineering and genome editing. , Induced pluripotent hepatocytes and other fields of rapid development. [0003] The Biobrick / Bglbrick method is a method that relies on isotail enzymes. Isotail enzymes (such as BglII and BamHI, Xba...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C07K1/22C12R1/84
Inventor 刘刚邵妤陈惠鹏金晶王微曲国龙阚乃鹏谭俊杰朱晨
Owner INST OF BIOENG ACAD OF MILITARY MEDICAL SCI OF THE CHINESE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products